title: Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.
abstract: Angiotensin-converting enzyme 2 (ACE2) catalyzes conversion of ANG II to ANG-(1-7). The present study uses newly established proteomic approaches and genetic mouse models to examine the contribution of alternative renal peptidases to ACE2-independent formation of ANG-(1-7). In situ and in vitro mass spectrometric characterization showed that substrate concentration and pH control renal ANG II processing. At pH ≥6, ANG-(1-7) formation was significantly reduced in ACE2 knockout (KO) mice. However, at pH <6, formation of ANG-(1-7) in ACE2 KO mice was similar to that in wild-type (WT) mice, suggesting alternative peptidases for renal ANG II processing. Furthermore, the dual prolyl carboxypeptidase (PCP)-prolyl endopeptidase (PEP) inhibitor Z-prolyl-prolinal reduced ANG-(1-7) formation in ACE2 KO mice, while the ACE2 inhibitor MLN-4760 had no effect. Unlike the ACE2 KO mice, ANG-(1-7) formation from ANG II in PEP KO mice was not different from that in WT mice at any tested pH. However, at pH 5, this reaction was significantly reduced in kidneys and urine of PCP-depleted mice. In conclusion, results suggest that ACE2 metabolizes ANG II in the kidney at neutral and basic pH, while PCP catalyzes the same reaction at acidic pH. This is the first report demonstrating that renal ANG-(1-7) formation from ANG II is independent of ACE2. Elucidation of ACE2-independent ANG-(1-7) production pathways may have clinically important implications in patients with metabolic and renal disease.
authors: Department of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, OH 45435, USA.
authors: Nadja
authors: N
authors: Grobe
authors: Nathan M
authors: NM
authors: Weir
authors: Orly
authors: O
authors: Leiva
authors: Frank S
authors: FS
authors: Ong
authors: Kenneth E
authors: KE
authors: Bernstein
authors: Alvin H
authors: AH
authors: Schmaier
authors: Mariana
authors: M
authors: Morris
authors: Khalid M
authors: KM
authors: Elased
mesh_terms: D000803:Angiotensin I / Q000652:urine*; D000804:Angiotensin II / Q000378:metabolism / Q000652:urine*; D000085962:Angiotensin-Converting Enzyme 2; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D002268:Carboxypeptidases / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000493:pharmacokinetics; D004151:Dipeptides / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D007668:Kidney / Q000378:metabolism; D007930:Leucine / Q000031:analogs & derivatives / Q000494:pharmacology; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D010446:Peptide Fragments / Q000652:urine*; D007703:Peptidyl-Dipeptidase A / Q000235:genetics / Q000378:metabolism*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
chemical_list: C486469:2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid; D000806:Angiotensin-Converting Enzyme Inhibitors; D004151:Dipeptides; D007093:Imidazoles; D010446:Peptide Fragments; D000804:Angiotensin II; C038541:N-benzyloxycarbonylprolylprolinal; D000803:Angiotensin I; D002268:Carboxypeptidases; D007703:Peptidyl-Dipeptidase A; C022448:lysosomal Pro-X carboxypeptidase; C000705328:Ace2 protein, mouse; D000085962:Angiotensin-Converting Enzyme 2; D007930:Leucine; C118790:angiotensin I (1-7)
keywords: angiotensin-converting enzyme 2; angiotensinase C; mass spectrometry; prolyl endopeptidase; renin-angiotensin system
references: Kidney Int. 2001 May;59(5):1626-40
references: 11318933
references: Hypertension. 2004 May;43(5):1120-5
references: 15078862
references: Hypertension. 2010 Jan;55(1):90-8
references: 19948988
references: Diabetes. 2008 Apr;57(4):1018-25
references: 18235039
references: Diabetes. 2010 Oct;59(10):2540-8
references: 20660625
references: Am J Physiol Renal Physiol. 2008 Jun;294(6):F1315-22
references: 18417539
references: Biochem Pharmacol. 1987 Oct 1;36(19):3187-93
references: 3478049
references: Clin J Am Soc Nephrol. 2007 Sep;2(5):883-8
references: 17702734
references: Hypertension. 2009 Aug;54(2):365-71
references: 19564552
references: Kidney Int. 2004 Feb;65(2):386-92
references: 14717908
references: Trends Pharmacol Sci. 2011 Dec;32(12):734-9
references: 21880378
references: Am J Physiol Renal Physiol. 2000 Nov;279(5):F841-50
references: 11053044
references: Am J Physiol Renal Physiol. 2011 Jan;300(1):F272-82
references: 20962118
references: Genes Cells. 1998 May;3(5):297-306
references: 9685181
references: Peptides. 1994;15(5):919-26
references: 7984514
references: J Am Soc Nephrol. 2006 Nov;17(11):3067-75
references: 17021266
references: Circ Res. 2006 Mar 3;98(4):463-71
references: 16514079
references: Diabetes. 2010 Feb;59(2):529-38
references: 19934006
references: J Biol Chem. 1993 Aug 5;268(22):16631-8
references: 8344943
references: Hypertension. 1992 Jun;19(6 Pt 2):692-6
references: 1317352
references: Clin J Am Soc Nephrol. 2010 Jul;5(7):1277-81
references: 20413437
references: Mol Ther. 2012 Jan;20(1):28-36
references: 21792177
references: J Clin Invest. 2009 Aug;119(8):2291-303
references: 19620781
references: Hypertension. 2012 Jun;59(6):1195-203
references: 22508831
references: Am J Physiol Cell Physiol. 2013 May 15;304(10):C939-40
references: 23552286
references: Diabetes. 2006 Jul;55(7):2132-9
references: 16804085
references: Nature. 2002 Jun 20;417(6891):822-8
references: 12075344
references: J Biol Chem. 2002 Apr 26;277(17):14838-43
references: 11815627
references: Biochem Biophys Res Commun. 1998 Sep 8;250(1):5-11
references: 9735321
references: Am J Physiol Endocrinol Metab. 2012 Apr 15;302(8):E1016-24
references: 22318946
references: J Cardiovasc Pharmacol Ther. 2013 Mar;18(2):138-51
references: 23043153
references: Hypertension. 2011 Feb;57(2):314-22
references: 21189404
references: Am J Physiol Renal Physiol. 2012 Jun 15;302(12):F1583-94
references: 22461301
references: J Biol Chem. 1978 Sep 10;253(17):5927-31
references: 28321
references: Hypertension. 2010 Jan;55(1):166-71
references: 19948986
references: Psychoneuroendocrinology. 2001 Jan;26(1):17-26
references: 11070331
references: Blood. 2011 Apr 7;117(14):3929-37
references: 21297000
references: Mass Spectrom Rev. 2007 May-Jun;26(3):324-39
references: 17405133
references: Int J Obes (Lond). 2009 Sep;33(9):1013-22
references: 19564876
references: Circ Res. 2000 Sep 1;87(5):E1-9
references: 10969042
references: Hypertension. 2006 May;47(5):1010-7
references: 16585421
references: Exp Physiol. 2008 May;93(5):538-42
references: 18376006
references: Biochem J. 1990 Oct 15;271(2):559-62
references: 2241932
references: Acta Diabetol. 2012 Aug;49(4):291-9
references: 22042130
references: Am J Physiol Renal Physiol. 2006 Jan;290(1):F214-22
references: 16118394
references: J Exp Med. 1956 Mar 1;103(3):295-9
references: 13295487
references: Kidney Int. 2012 Aug;82(3):292-303
references: 22475818
references: Mol Med. 2011 Jan-Feb;17(1-2):59-69
references: 20844835
references: Hypertension. 2011 Dec;58(6):1057-65
references: 22025374
references: Biochemistry. 2003 Nov 18;42(45):13185-92
references: 14609329
references: Exp Physiol. 2005 Sep;90(5):783-90
references: 16049057
references: J Biol Chem. 2000 Oct 27;275(43):33238-43
references: 10924499
references: Circ Res. 2010 Feb 5;106(2):373-82
references: 19926873
references: Hypertension. 2005 Oct;46(4):953-9
references: 16103259
references: Am J Kidney Dis. 2006 Dec;48(6):905-15
references: 17162145
references: Hypertension. 2006 Apr;47(4):718-26
references: 16505206
references: Life Sci. 1993;52(18):1461-80
references: 8387132
references: Am J Pathol. 2007 Aug;171(2):438-51
references: 17600118
references: J Clin Invest. 2006 Aug;116(8):2218-25
references: 16878172